Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GHTF Members To Discuss Draft Procedures Document At Upcoming Meeting

This article was originally published in The Gray Sheet

Executive Summary

The Global Harmonization Task Force's recently released draft document, "Guiding Principles and Operating Procedures," likely will trigger considerable debate between FDA and reps from other GHTF-member countries' regulatory bodies, as well as industry trade groups, at the seventh annual GHTF conference June 27-July 2 in Washington, D.C.

You may also be interested in...



GHTF Procedures Debate To Be Settled By Ad Hoc Committee

The Global Harmonization Task Force will form an ad hoc working group to assess options for formalizing the group's procedures, GHTF members agreed during the June 29 plenary session of the task force's annual meeting in Bethesda, Maryland.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT011941

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel